Paradigm Biopharmaceuticals
Paradigm Biopharmaceuticals Logo
About Paradigm Biopharmaceuticals
Paradigm Biopharmaceuticals Ltd is an Australian biopharmaceutical company focused on the research and development of therapeutic products for human use. The company’s lead candidate, Zilosul, is an injectable pentosan polysulfate sodium drug being developed for the treatment of osteoarthritis, mucopolysaccharidosis, and a range of other diseases including viral and respiratory conditions. Paradigm Biopharmaceuticals specializes in late-stage drug development, aiming to address significant unmet medical needs through innovative approaches to drug repurposing and clinical advancement.
Address
500 Collins Street, Level 15
Melbourne, 3000
Australia
Year founded
2014
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
